J-Star Holding
YMAT

J-Star Holding (YMAT) news

Recent news

Chinese Taiwan stocks fell in intraday trading, with YMAT down 18.7%, IMOS falling 4.5% and KBSX sliding 3.6%.

Chinese Taiwan stocks experienced a decline in intraday trading on October 13, 2026, with several key equities showing notable downward movement. Among the most actively traded names, YMAT, the ticker for J-Star Holding Co. Ltd., fell by 18.7% , marking a sharp reversal from recent volatility seen…

AInvest Wire · 4h ago

Trading released/resumed: Ymat) Reason not available

On October 12, 2026, trading for J-Star Holding Co. (Nasdaq: YMAT) resumed following a prior halt, though the specific reason for the halt remains unavailable at this time. According to NASDAQ trading halt codes, a "Space" designation indicates that the cause for the halt has not been disclosed.…

AInvest Wire · 1d ago

Trading released/resumed: (Ymat) Reason not available

Trading in shares of J-Star Holding Co., Ltd. (NASDAQ: YMAT) resumed on October 12, 2026, following a period of market volatility. The stock closed at $2.03 per share, reflecting a 64.63% decline from its previous session’s close. The resumption of trading occurred without a publicly disclosed…

AInvest Wire · 1d ago

Trading halted: (YMAT) Due to limit-up limit-down trading pause

Trading in the stock of J-Star Holding Co., Ltd. (YMAT) was temporarily halted on October 12, 2026, due to the activation of a limit-up limit-down trading pause mechanism. This pause is triggered when a stock’s price moves beyond predefined thresholds within a short period, typically to allow for a…

AInvest Wire · 1d ago

Quoin Pharmaceuticals Ltd: BTIG initiates coverage with buy rating; target price $14

BTIG, a financial services firm, has initiated coverage on Quoin Pharmaceuticals Ltd with a "buy" rating and a target price of $14 per share. The recommendation reflects the firm’s assessment of the company’s current market position and potential for growth. While no detailed analysis or specific…

AInvest Wire · 1d ago

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.